Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Drug is a South Korean pharmaceutical company established in 1984 that specializes in the development, manufacturing, and distribution of a wide range of medicinal products. The company produces various finished dosage forms including tablets, capsules, and injections, covering therapeutic areas such as gastrointestinal health, circulatory systems, and respiratory care. Korea Drug operates advanced manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure high-quality production for both domestic and international markets. In addition to its own branded products, the company engages in the production of active pharmaceutical ingredients (APIs) and provides contract manufacturing services. Korea Drug continues to expand its portfolio through steady research and development focused on improving drug delivery and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Drug.